Transgene SA
TRGNF
$0.70
-$0.89-55.98%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -52.26% | -4.25% | 29.14% | 28.70% | 30.03% |
| Total Depreciation and Amortization | -18.48% | -15.96% | -13.35% | -7.71% | -4.34% |
| Total Amortization of Deferred Charges | -82.94% | -7.17% | 298.84% | 298.84% | 298.84% |
| Total Other Non-Cash Items | 79.98% | -54.55% | -719.12% | -614.70% | -526.23% |
| Change in Net Operating Assets | 252.45% | 140.63% | -7.06% | -3,319.47% | -234.27% |
| Cash from Operations | 32.09% | 11.07% | -12.59% | -38.79% | -78.27% |
| Capital Expenditure | -14.98% | -23.01% | -31.99% | -53.18% | -86.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.38% | -73.69% | -42.12% | 6.16% | 77.10% |
| Cash from Investing | -109.28% | -81.45% | -48.34% | 2.41% | 76.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.03% | -22.25% | -39.58% | -15.83% | 7.31% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 124.50% | 228.38% | 20,000.00% | 20,761.60% | 6,676.44% |
| Cash from Financing | 136.86% | 469.49% | 2,795.73% | 1,750.15% | 872.20% |
| Foreign Exchange rate Adjustments | 11,473.68% | 6,489.22% | 3,504.72% | 3,540.32% | -2,000.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.08% | 55.70% | 457.56% | 597.39% | 950.85% |